SurOL: Surgery for oral leukoplakia (a white patch in the mouth)

ISRCTN ISRCTN12617344
DOI https://doi.org/10.1186/ISRCTN12617344
Secondary identifying numbers DSarduino15
Submission date
11/11/2019
Registration date
28/11/2019
Last edited
02/12/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Digestive System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Background and study aims
Leukoplakia is a white patch in the mouth. The WHO Collaborating Centres for Oral Precancerous conditions have clinically defined the term oral leukoplakia (OL) as “white mucosal lesions that have a risk of progressing to squamous carcinoma”. To date, the term OL should be used to recognize “predominantly white plaques of questionable risk having excluded (other) known diseases or disorders that carry no increased risk for cancer”. The vast majorities of OLs are localized lesions and follow a benign course. Small subsets of these lesions can become cancerous.
The aim of this study was to assess the effectiveness of surgery in the treatment of OL, in order to compare the "wait and see" approach in term of possible malignant transformation.

Who can participate?
Caucasian patients aged 18 years or above, with OL without signs of cancer

What does the study involve?
Participants will be randomly assigned to receive either surgical removal of the OL, or treatment as usual

What are the possible benefits and risks of participating?
None

Where is the study run from?
CIR-Dental School, University of Turin, Italy

When is the study starting and how long is it expected to run for?
January 2012 to December 2014

Who is funding the study?
Università degli Studi di Torino (University of Turin), Italy

Who is the main contact?
Prof. Paolo G. Arduino
paologiacomo.arduino@unito.it

Contact information

Prof Paolo G Arduino
Public

Via Nizza 230
Turin
10126
Italy

ORCiD logoORCID ID 0000-0002-8798-7834
Phone 00390116331522
Email paologiacomo.arduino@unito.it

Study information

Study designTwo arm randomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleA randomized no intervention-controlled trial of surgery in oral leukoplakia with no dysplasia
Study acronymSurOL
Study hypothesisThe aim of this study is to evaluate the surgical outcome of patients diagnosed with an oral leukoplakia without dysplasia, compared to patients with the same diagnosis who did not undergo surgery
Ethics approval(s)Approved 07/01/2009, CIR-Dental School (Via Nizza 230, Turin, 10126, Italy; segr_cirdental@unito.it), ref: AP-RB2009/1234
ConditionOral leukoplakia with no signs of dysplasia
InterventionConsecutive Caucasian patients, attending the Oral Medicine Section of the Department of Surgical Sciences, Turin Hospital, Italy, from January 2012 and December 2013, are selected for the present study. Participants are randomly divided into two groups. Allocation to treatment arms is performed using sequentially numbered randomization table. RANCODE (version 3.6) is used to generate the randomization sequence.

The first group of patients undergo surgical excision of the lesion with a traditional scalpel, (GROUP A_TS) whereas the second group of patients are followed up with no surgical session (GROUP B_NS).

The period of follow up is 5 years.
Intervention typeProcedure/Surgery
Primary outcome measureMalignant transformation of the biopsied lesion measured using visual inspection by a physician every six months
Secondary outcome measuresProgression of the disease measured using visual inspection by a physician every six months
Overall study start date01/01/2012
Overall study end date01/01/2020

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants300
Total final enrolment260
Participant inclusion criteria1. Caucasian patients, attending the Oral Medicine Section of the Department of Surgical Sciences, Turin Hospital
2. Diagnosis of oral leukoplakia with no signs of dysplasia
3. Adults aged 18 and older
Participant exclusion criteria1. Patients with a previous diagnosis of oral cancer.
2. Pregnant or lactating females; patients with incapacity to understand verbal and written instructions
Recruitment start date01/01/2012
Recruitment end date30/12/2014

Locations

Countries of recruitment

  • Italy

Study participating centre

CIR-Dental School; University of Turin
Via Nizza 230
Turin
10126
Italy

Sponsor information

University of Turin
University/education

Via Nizza 230
Turin
10126
Italy

Phone +39 (0)116331522
Email paologiacomo.arduino@unito.it
Website http://www.dentalschool.unito.it
ROR logo "ROR" https://ror.org/048tbm396

Funders

Funder type

University/education

Università degli Studi di Torino
Government organisation / Universities (academic only)
Alternative name(s)
University of Turin in Italy, University of Turin, Italy, Università di Torino, 都灵大学, University of Turin, UNITO
Location
Italy

Results and Publications

Intention to publish date01/06/2020
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a peer reviewed journal.
IPD sharing planThe datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/09/2020 02/12/2020 Yes No

Editorial Notes

02/12/2020: The following changes were made to the trial record:
1. Publication reference added.
2. The total final enrolment was added.
12/11/2019: Trial’s existence confirmed by CIR-Dental School